KOSPI · 271980 · Biotech & Pharma · ₩271980

Jeil Pharmaceutical제일약품

271980 · KOSPI · ₩271980 · 제일약품

₩8,830 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
Disclosure of Corporate Governance Report기업지배구조보고서공시Jun 1, 2026Open on DART
Amended: Quarterly report (Mar 2026)[기재정정]분기보고서 (2026.03)May 18, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
5%+ holding report주식등의대량보유상황보고서(일반)Apr 30, 2026Open on DART
Amended: Annual general meeting results[기재정정]정기주주총회결과Mar 25, 2026Open on DART
Annual general meeting results정기주주총회결과Mar 24, 2026Open on DART
Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 24, 2026Open on DART
Audit report submitted감사보고서제출Mar 16, 2026Open on DART
Annual report (Dec 2025)사업보고서 (2025.12)Mar 16, 2026Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 9, 2026Open on DART
Shareholders' meeting called주주총회소집결의Mar 5, 2026Open on DART
Report on Results of Disposal of Treasury Shares자기주식처분결과보고서Feb 26, 2026Open on DART
Treasury share sale decision주요사항보고서(자기주식처분결정)Feb 25, 2026Open on DART
Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Feb 23, 2026Open on DART
Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
Half-year report (Jun 2025)반기보고서 (2025.06)Aug 14, 2025Open on DART
[Amendment] Disclosure of Corporate Governance Report[기재정정]기업지배구조보고서공시Jun 4, 2025Open on DART
Disclosure of Corporate Governance Report기업지배구조보고서공시May 29, 2025Open on DART
Quarterly report (Mar 2025)분기보고서 (2025.03)May 15, 2025Open on DART
Change of Representative Director (Representative Executive Officer) (Informational Disclosure)대표이사(대표집행임원)변경(안내공시)Mar 25, 2025Open on DART
Annual general meeting results정기주주총회결과Mar 25, 2025Open on DART
Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 25, 2025Open on DART
Audit report submitted감사보고서제출Mar 17, 2025Open on DART
Annual report (Dec 2024)사업보고서 (2024.12)Mar 17, 2025Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 10, 2025Open on DART
Shareholders' meeting called주주총회소집결의Mar 5, 2025Open on DART
Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Feb 24, 2025Open on DART
Amended: Rights offering (paid-in capital increase) decision[기재정정]유상증자결정(종속회사의주요경영사항)Dec 5, 2024Open on DART
Quarterly report (Sep 2024)분기보고서 (2024.09)Nov 14, 2024Open on DART
Amended: Rights offering (paid-in capital increase) decision[기재정정]유상증자결정(종속회사의주요경영사항)Nov 8, 2024Open on DART
Rights offering (paid-in capital increase) decision유상증자결정(종속회사의주요경영사항)Oct 16, 2024Open on DART
Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 25, 2024Open on DART
Major sales or supply contract단일판매ㆍ공급계약체결Sep 5, 2024Open on DART
Half-year report (Jun 2024)반기보고서 (2024.06)Aug 14, 2024Open on DART
Quarterly report (Mar 2024)분기보고서 (2024.03)May 16, 2024Open on DART
Annual general meeting results정기주주총회결과Mar 20, 2024Open on DART
Audit report submitted감사보고서제출Mar 12, 2024Open on DART
Annual report (Dec 2023)사업보고서 (2023.12)Mar 12, 2024Open on DART
Notice of shareholders' meeting주주총회소집공고Mar 5, 2024Open on DART
Cash dividend decision현금ㆍ현물배당결정Feb 27, 2024Open on DART
Shareholders' meeting called주주총회소집결의Feb 27, 2024Open on DART
Change in revenue or profit of 30% or more매출액또는손익구조30%(대규모법인은15%)이상변경Feb 20, 2024Open on DART
Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Dec 12, 2023Open on DART
Major sales or supply contract단일판매ㆍ공급계약체결Dec 11, 2023Open on DART
Quarterly report (Sep 2023)분기보고서 (2023.09)Nov 13, 2023Open on DART
Half-year report (Jun 2023)반기보고서 (2023.06)Aug 11, 2023Open on DART
Quarterly report (Mar 2023)분기보고서 (2023.03)May 12, 2023Open on DART
Annual general meeting results정기주주총회결과Mar 24, 2023Open on DART
독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 24, 2023Open on DART

Titles in Korean until English translations are added.

Also known as: Jeil Pharmaceutical / 제일약품 / 271980 / KRX:271980

Source: KRX statistical information